Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19808 | 26338727 | Gut | The gut microbiota and host health: a new clinical frontier. | 2015 | Details |
| A19809 | 26337107 | Curr Med Chem | Emerging Vascular Risk Factors in Women: Any Differences from Men? | 2015 | Details |
| A19810 | 26335400 | Redox Biol | Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences. | 2015 | Details |
| A19815 | 26330344 | Am J Physiol Endocrinol Metab | Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. | 2015 | Details |
| A19817 | 26329758 | Digestion | Tissue Inhibitors of Metalloproteinase-1 and 2 and Obesity Related Non-Alcoholic Fatty Liver Disease: Is There a Relationship. | 2015 | Details |
| A19819 | 26328027 | World J Hepatol | Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. | 2015 | Details |
| A19821 | 26327768 | World J Gastroenterol | Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. | 2015 | Details |
| A19824 | 26325428 | Biochem Biophys Res Commun | Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. | 2015 | Details |
| A19825 | 26323878 | Nat Rev Gastroenterol Hepatol | Caring for children with NAFLD and navigating their care into adulthood. | 2015 | Details |
| A19834 | 26316717 | Drug Des Devel Ther | Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. | 2015 | Details |
| A19835 | 26316434 | J Clin Res Pediatr Endocrinol | Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19836 | 26316333 | Sci Rep | GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance. | 2015 | Details |
| A19837 | 26315844 | Int J Obes (Lond) | Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment. | 2015 | Details |
| A19842 | 26314837 | J Gastroenterol | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. | 2015 | Details |
| A19843 | 26314479 | Eur Radiol | Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. | 2015 | Details |
| A19848 | 26310987 | Int J Cardiol | Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. | 2015 | Details |
| A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
| A19851 | 26307979 | Int J Mol Sci | Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link? | 2015 | Details |
| A19852 | 26305052 | Biochem Cell Biol | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 | Details |
| A19860 | 26300331 | J Nutr Biochem | Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. | 2015 | Details |
| A19862 | 26299811 | Toxicology | Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases. | 2015 | Details |
| A19865 | 26298775 | Sleep Med | Evaluation of circulating markers of hepatic apoptosis and inflammation in obese children with and without obstructive sleep apnea. | 2015 | Details |
| A19867 | 26297911 | Biochem Pharmacol | A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | 2015 | Details |
| A19875 | 26290633 | World J Gastroenterol | Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions. | 2015 | Details |
| A19876 | 26290284 | Front Med | Molecular mechanisms of fatty liver in obesity. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A19884 | 26284975 | Biochem Biophys Res Commun | Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity. | 2015 | Details |
| A19885 | 26284591 | Clin Gastroenterol Hepatol | Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. | 2015 | Details |
| A19886 | 26283807 | Anc Sci Life | Efficacy of herbomineral compounds and pathya (Ayurvedic dietary regime and physical exercise) in the management of Yakṛt Roga (Non-alcoholic fatty liver disease). | 2015 | Details |
| A19887 | 26283505 | Eur J Nucl Med Mol Imaging | The role of active brown adipose tissue in human metabolism. | 2015 | Details |
| A19889 | 26282529 | Proc Nutr Soc | Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice. | 2015 | Details |
| A19893 | 26280342 | FP Essent | Metabolic Syndrome: Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19898 | 26278393 | Curr Mol Pharmacol | Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances. | 2017 | Details |
| A19905 | 26273621 | Biomed Res Int | Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. | 2015 | Details |
| A19906 | 26273620 | Biomed Res Int | Improvement of BMI after Lifestyle Intervention Is Associated with Normalisation of Elevated ELF Score and Liver Stiffness in Obese Children. | 2015 | Details |
| A19907 | 26273604 | Biomed Res Int | The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19908 | 26273598 | Biomed Res Int | Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis. | 2015 | Details |
| A19909 | 26273591 | Biomed Res Int | Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. | 2015 | Details |
| A19913 | 26271188 | Int J Obes (Lond) | Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19925 | 26262841 | J Agric Food Chem | Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. | 2015 | Details |
| A19926 | 26261693 | World J Hepatol | Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. | 2015 | Details |
| A19927 | 26260846 | Biochim Biophys Acta | 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism. | 2015 | Details |
| A19928 | 26260755 | Gut Liver | Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. | 2016 | Details |
| A19930 | 26258810 | Eur J Cancer Prev | Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis. | 2016 | Details |
| A19932 | 26256903 | Ann Hepatol | Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. | 2016 | Details |
| A19933 | 26256895 | Ann Hepatol | SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women. | 2016 | Details |
| A19938 | 26255044 | Gastroenterology | Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. | 2015 | Details |
| A19941 | 26252899 | PLoS One | Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. | 2015 | Details |
| A19945 | 26250831 | Dig Dis Sci | Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. | 2015 | Details |
| A19947 | 26250514 | Obesity (Silver Spring) | Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. | 2015 | Details |
| A19948 | 26247669 | Clinics (Sao Paulo) | Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. | 2015 | Details |
| A19953 | 26242978 | Lipids Health Dis | Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A19957 | 26241028 | J Steroid Biochem Mol Biol | Glucocorticoids and non-alcoholic fatty liver disease. | 2015 | Details |
| A19958 | 26240695 | World J Diabetes | Metabolic surgery: A paradigm shift in type 2 diabetes management. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19970 | 26233911 | Adv Pharmacol | Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. | 2015 | Details |
| A19971 | 26233836 | Pharmacoeconomics | Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19974 | 26231377 | Drug Metab Dispos | CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19975 | 26229968 | J Diabetes Res | Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints. | 2015 | Details |
| A19981 | 26228038 | Lipids Health Dis | Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. | 2015 | Details |
| A19984 | 26226097 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. | 2015 | Details |
| A19996 | 26215699 | J Pharmacol Sci | JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis. | 2015 | Details |
| A19997 | 26215532 | Am J Gastroenterol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | 2015 | Details |
| A20000 | 26215259 | Nat Rev Endocrinol | Physiological and pathophysiological roles of NAMPT and NAD metabolism. | 2015 | Details |
| A20003 | 26214605 | Obes Rev | Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization. | 2015 | Details |
| A20004 | 26214582 | Lab Invest | Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. | 2015 | Details |
| A20007 | 26211668 | Endocr J | A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease. | 2015 | Details |
| A20013 | 26204635 | Rev Med Chir Soc Med Nat Iasi | NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMPLICATIONS--ASSESSING THE POPULATION AT RISK. A SMALL SERIES REPORT AND LITERATURE REVIEW. | 2015 | Details |
| A20017 | 26203166 | J Endocrinol | Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. | 2015 | Details |
| A20019 | 26202539 | Br J Nutr | Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study. | 2015 | Details |
| A20023 | 26201461 | Drugs | Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. | 2015 | Details |
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20034 | 26198708 | Wiley Interdiscip Rev RNA | 'Micro-managers' of hepatic lipid metabolism and NAFLD. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20040 | 26194256 | Surg Endosc | Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. | 2015 | Details |
| A20043 | 26193757 | Int J Urol | Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review. | 2015 | Details |
| A20050 | 26190559 | Food Funct | Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. | 2015 | Details |
| A20060 | 26186426 | J Med Food | Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20065 | 26182253 | Dtsch Med Wochenschr | [Non-alcoholic fatty liver disease (NAFLD)]. | 2015 | Details |
| A20072 | 26175982 | Iran J Public Health | Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. | 2014 | Details |
| A20073 | 26174847 | Sleep Breath | Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. | 2015 | Details |
| A20074 | 26174761 | Arab J Gastroenterol | Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit? | 2015 | Details |
| A20076 | 26173075 | Menopause | Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. | 2016 | Details |
| A20077 | 26172853 | Biochim Biophys Acta | Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression. | 2015 | Details |
| A20082 | 26169265 | Cardiovasc Diabetol | Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. | 2015 | Details |
| A20085 | 26167414 | Adipocyte | The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. | 2015 | Details |
| A20086 | 26167390 | J Clin Imaging Sci | The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. | 2015 | Details |
| A20087 | 26167252 | World J Hepatol | Non-alcohol fatty liver disease in Asia: Prevention and planning. | 2015 | Details |
| A20088 | 26167244 | World J Hepatol | Is there a role for adaptive immunity in nonalcoholic steatohepatitis? | 2015 | Details |
| A20090 | 26166101 | Medicine (Baltimore) | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20093 | 26159457 | Sci Rep | Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice. | 2015 | Details |
| A20094 | 26159280 | Dig Dis | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. | 2015 | Details |
| A20099 | 26155623 | Ter Arkh | [Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20111 | 26148225 | Liver Int | I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. | 2015 | Details |
| A20115 | 26147081 | Nature | The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. | 2015 | Details |
| A20117 | 26144271 | Metabolism | Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study. | 2015 | Details |